Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Net Margin (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Net Margin for 2 consecutive years, with 164.16% as the latest value for Q4 2025.

  • Quarterly Net Margin changed N/A to 164.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 576.32% through Dec 2025, down 8445.0% year-over-year, with the annual reading at 574.65% for FY2025, 9570.0% down from the prior year.
  • Net Margin for Q4 2025 was 164.16% at Pyxis Oncology, up from 640.82% in the prior quarter.
  • The five-year high for Net Margin was 33.09% in Q1 2024, with the low at 640.82% in Q2 2025.